Development of MEDI4736, an anti-programmed cell death ligand 1 (PD-L1) antibody, as monotherapy or in combination with other therapies in the treatment of non-small cell lung cancer (NSCLC)

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 7 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

THERAPEUTIC COMBINATIONS AND METHODS FOR TREATING NEOPLASIA

Application WO-2016079049-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.